| Issue |
Section |
Title |
File |
| Vol 16, No 4 (2017) |
Статьи |
Identification of medulloblastoma molecular subgroups by gene expression profiling |
(Rus)
|
| Vol 17, No 1 (2018) |
Статьи |
Molecular characterization of pediatric acute myeloid leukemia with t(8;21) |
(Rus)
|
| Vol 17, No 1 (2018) |
Статьи |
Autoimmune diseases in children with acquired aplastic anemia |
(Rus)
|
| Vol 17, No 1 (2018) |
Статьи |
Fisher–Evans syndrome |
(Rus)
|
| Vol 17, No 1 (2018) |
Статьи |
Liquid Biopsy in Pediatric Brain Cancers: A Theragnostic Opportunity |
(Rus)
|
| Vol 16, No 2 (2017) |
Статьи |
The use of eltrombopag in children and young adults with acquired aplastic anemia |
(Rus)
|
| Vol 16, No 2 (2017) |
Статьи |
Organization of medical care for children with hematological diseases |
(Rus)
|
| Vol 16, No 3 (2017) |
Статьи |
Implementation of the algorithm of empirical antibacterial therapy for febrile neutropenia in the Сenter of pediatric hematology/oncology |
(Rus)
|
| Vol 16, No 3 (2017) |
Статьи |
Dynamics of platelet functional activity and hemostatic status in a child with chronic immune thrombocytopenia on romiplostim treatment |
(Rus)
|
| Vol 16, No 1 (2017) |
Статьи |
MYH9-related inherited thrombocytopenia |
(Rus)
|
| Vol 14, No 1 (2015) |
ОСТРЫЙ ЛИМФОБЛАСТНЫЙ ЛЕЙКОЗ |
Comparative analysis of dexamethasone and methylprednisolone efficacy in induction therapy of childhood acute lymphoblastic leukemia: Results of ALL-MB 2002 multicenter study |
(Rus)
|
| Vol 14, No 4 (2015) |
CLINICAL OBSERVATIONS |
Development of neuroblastoma in a child with Shereshevsky-Turner’s syndrome |
(Rus)
|
| Vol 17, No 2 (2018) |
PROMISING STUDIES |
Low dose donor memory T-cell infusion after TCR alpha/beta depleted stem cell transplantation for patients with malignant disorders |
(Rus)
|
| Vol 17, No 2 (2018) |
ORIGINAL ARTICLES |
Late effects after treosulfan- and busulfan-based myeloablative conditioning for allogeneic HSCT in children with malignant diseases: a comparative study |
(Rus)
|
| Vol 17, No 2 (2018) |
LITERATURE REVIEW |
New advances in pathogenesis, diagnostic and treatment of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation |
(Rus)
|
| Vol 17, No 3 (2018) |
PROMISING STUDIES |
Prognostic value of molecular, genetic and clinical characteristics of SHH group medulloblastoma |
(Rus)
|
| Vol 18, No 1 (2019) |
ORIGINAL ARTICLES |
Therapeutic aspects, determining the outcome of deep veins thrombosis (dvt) in children with hematological diseases |
(Rus)
|
| Vol 18, No 1 (2019) |
ORGANIZATION OF HEALTHCARE |
Difficulties of the federal centers providing the profile medical assistance |
(Rus)
|
| Vol 18, No 1 (2019) |
ORGANIZATION OF HEALTHCARE |
The effectiveness of the information system for managing data from a registration study of acute myeloid leukemia in children |
(Rus)
|
| Vol 18, No 2 (2019) |
PROMISING STUDIES |
αβ-T-cell-depleted haploidentical hematopoietic stem cell transplantation in children with chemorefractory acute myeloid leukemia |
(Rus)
|
| Vol 18, No 2 (2019) |
ORIGINAL ARTICLES |
The thoracic air-leak syndrome (TALS): the frequency of occurrence and radiological signs in the structure of late non-infectious lung lesions in children after the allogeneic HSСT |
(Rus)
|
| Vol 18, No 3 (2019) |
ORIGINAL ARTICLES |
Epilemiological characteristics of Diamond–Blackfen anemia in pediatric population of the Russian Federation |
(Rus)
|
| Vol 18, No 4 (2019) |
PROMISING STUDIES |
Clinical and molecular characteristics of WNT medulloblastomas |
(Rus)
|
| Vol 19, No 1 (2020) |
PROMISING STUDIES |
The results of treatment in children with AML and initial hyperleucocytosis according to the AML-MM-2006 Protocol |
(Rus)
|
| Vol 19, No 1 (2020) |
ORIGINAL ARTICLES |
Use of romiplostim for newly diagnosed immune thrombocytopenia in children |
(Rus)
|
| Vol 19, No 1 (2020) |
EDITORIAL |
Updated 2020 guidelines for diagnosis and treatment of invasive aspergillosis in children with hematologic malignancy |
(Rus)
|
| Vol 19, No 2 (2020) |
ПЕРЕДОВАЯ СТАТЬЯ |
Hematopoietic stem cell transplantation in children in Russia: a brief overview of activity in 2015–2018 |
(Rus)
|
| Vol 19, No 3 (2020) |
ORIGINAL ARTICLES |
Organizational aspects of acute massive blood loss therapy in pediatric surgical oncology |
(Rus)
|
| Vol 19, No 3 (2020) |
LITERATURE REVIEW |
Noninvasive assessment of iron overload by magnetic resonance imaging |
(Rus)
|
| Vol 19, No 3 (2020) |
EDITORIAL |
Possibilities, difficulties and prospects for using telemedicine technologies in the field of pediatric oncohematology |
(Rus)
|
| Vol 19, No 4 (2020) |
ORIGINAL ARTICLES |
Hepatoblastoma relapses after front-line therapy according to SIOPEL protocols: clinical characteristics and outcome |
(Rus)
|
| Vol 19, No 4 (2020) |
ORIGINAL ARTICLES |
Low-grade gliomas with the V600E mutation in the BRAF gene in children: clinical features and treatment options |
(Rus)
|
| Vol 19, No 4 (2020) |
LITERATURE REVIEW |
The prevention and treatment of chemotherapy-induced nausea and vomiting in children and adolescents receiving cancer treatment: the current status and possibilities for improvement |
(Rus)
|
| Vol 19, No 4 (2020): supplement |
MATERIALS OF THE 3rd WORKING MEETING OF ALLERGISTS-IMMUNOLOGISTS |
Influence of clinical and immunophenotypic variants of severe combined immunodeficiency on severity and outcomes of opportunistic infections |
(Rus)
|
| Vol 19, No 4 (2020): supplement |
MATERIALS OF THE 3rd WORKING MEETING OF ALLERGISTS-IMMUNOLOGISTS |
The efficacy and safety of romiplostim in the treatment of thrombocytopenia in pediatric patients with Wiskott–Aldrich syndrome: the results of a retrospective study |
(Rus)
|
| Vol 19, No 4 (2020): supplement |
MATERIALS OF THE 3rd WORKING MEETING OF ALLERGISTS-IMMUNOLOGISTS |
Characteristics of a group of patients with WHIM syndrome |
(Rus)
|
| Vol 20, No 1 (2021) |
PROMISING STUDIES |
Acute lymphoblastic leukemia in children with Down syndrome: “Moscow–Berlin” experience |
(Rus)
|
| Vol 20, No 1 (2021) |
ORIGINAL ARTICLES |
Results of the use of cladribine in children with acute myeloid leukemia in the treatment according to the AML-MM-2006 protocol |
(Rus)
|
| Vol 20, No 1 (2021) |
ORIGINAL ARTICLES |
Immunophenotypic characterization of pediatric acute myeloid leukemia with inv(16)(p13.1q22)/t(16;16)(p13.1;q22)/CBFb-MYH11 |
(Rus)
|
| Vol 20, No 1 (2021) |
ORIGINAL ARTICLES |
Specifities of the storage pool and morphology of platelets in children with unspecified hemorrhagic syndrome |
(Rus)
|
| Vol 20, No 1 (2021) |
ORIGINAL ARTICLES |
Choroid plexus carcinoma in children |
(Rus)
|
| Vol 20, No 1 (2021) |
ORIGINAL ARTICLES |
Rhabdomyosarcoma in the first year of life. Experience of Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology |
(Rus)
|
| Vol 20, No 1 (2021) |
CLINICAL OBSERVATIONS |
Thiopurine-induced myelotoxicity in patients with acute leukemia and benefits of preemptive pharmacogenetic testing prior to 6-mercaptopurine prescription |
(Rus)
|
| Vol 20, No 3 (2021) |
ORIGINAL ARTICLES |
Thrombopoietin receptor agonists for the treatment of severe persistent and chronic immune trombocytopenia in children: clinical data of Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology |
(Rus)
|
| Vol 20, No 3 (2021) |
ORIGINAL ARTICLES |
Thrombopoietin receptor agonists for the treatment of severe persistent and chronic immune trombocytopenia in children: clinical data of Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology |
(Rus)
|
| Vol 20, No 3 (2021) |
ORIGINAL ARTICLES |
Targeted therapy of hemispheric infant gliomas |
(Rus)
|
| Vol 20, No 3 (2021) |
ORIGINAL ARTICLES |
Kaposiform hemangioendothelioma/Kasabach–Merritt syndrome. Сlinical and laboratory characteristics. Analysis of clinical cases |
(Rus)
|
| Vol 20, No 3 (2021) |
CLINICAL OBSERVATIONS |
Intracranial hemorrhages in children with immune thrombocytopenia |
(Rus)
|
| Vol 20, No 3 (2021) |
SCHOOL OF IMMUNOLOGY – EXPERT OPINION |
Clinical case of type I interferonopathy: homozygous STAT2 gain-of-function mutation |
(Rus)
|
| Vol 20, No 4 (2021) |
ORIGINAL ARTICLES |
Choroid plexus papilloma and atypical choroid plexus papilloma in children: treatment results |
(Rus)
|
| Vol 20, No 4 (2021) |
ORIGINAL ARTICLES |
The novel coronavirus disease (COVID-19) in children with cancer, hematologic malignancies, and severe immunodeficiencies. Results of monocenter study |
(Rus)
|
| Vol 21, No 1 (2022) |
ПЕРЕДОВАЯ СТАТЬЯ |
Analysis of genetic aberrations in pediatric low-grade gliomas: the experience of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology |
(Rus)
|
| Vol 21, No 1 (2022) |
ORIGINAL ARTICLES |
The outcomes of children with acute myeloid leukemia treated in accordance with the AML–MM-2006 protocol |
(Rus)
|
| Vol 21, No 1 (2022) |
ORIGINAL ARTICLES |
Low specificity of HLA-DR expression for diagnosis of acute promyelocytic leukemia |
(Rus)
|
| Vol 21, No 2 (2022) |
ORIGINAL ARTICLES |
The THROMB-HEM study: first results and future prospects |
(Rus)
|
| Vol 21, No 3 (2022) |
ORIGINAL ARTICLES |
An autoinflammatory disease – PFAPA syndrome: a single-center experience |
(Rus)
|
| Vol 21, No 3 (2022) |
ORIGINAL ARTICLES |
High-risk acute lymphoblastic leukemia in the ALL-MB 2002 study |
(Rus)
|
| Vol 21, No 4 (2022) |
ORIGINAL ARTICLES |
A pharmacoeconomic study of pegaspargase in the treatment of pediatric acute lymphoblastic leukemia in Russia |
(Rus)
|
| Vol 22, No 1 (2023) |
ORIGINAL ARTICLES |
The assessment of the efficacy and safety of the personalized rehabilitation of the second stage using modern methods and technologies in children with primary immunodeficiencies |
(Rus)
|
| Vol 22, No 1 (2023) |
ORIGINAL ARTICLES |
The evaluation of minimal disseminated disease in the bone marrow of children with Burkitt lymphoma using next generation sequencing |
(Rus)
|
| Vol 22, No 1 (2023) |
ORIGINAL ARTICLES |
The use of inotuzumab ozogamicin in children with relapsed/refractory B-lineage acute lymphoblastic leukemia |
(Rus)
|
| Vol 22, No 1 (2023) |
DIAGNOSTIC GUIDELINES |
Flow cytometry in acute leukemia diagnostics. Guidelines of Russian-Belarusian multicenter group for pediatric leukemia studies |
(Rus)
|
| Vol 22, No 3 (2023) |
ORIGINAL ARTICLES |
Quantitative bone marrow magnetic resonance imaging in children with lymphoblastic leukaemia |
(Rus)
|
| Vol 22, No 2 (2023) |
ORIGINAL ARTICLES |
The results of therapy in patients with high-risk neuroblastoma: the experience of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology |
(Rus)
|
| Vol 22, No 2 (2023) |
CLINICAL OBSERVATIONS |
Kaposiform lymphangiomatosis with Kasabach–Merritt phenomenon |
(Rus)
|
| Vol 22, No 2 (2023) |
DIAGNOSTIC GUIDELINES |
Guidelines for the flow cytometric minimal residual disease monitoring in B-lineage acute lymphoblastic leukemia after CD19-directed immunotherapy |
(Rus)
|
| Vol 22, No 3 (2023) |
DIAGNOSTIC GUIDELINES |
Minimal residual disease monitoring in B-lineage acute lymphoblastic leukemia using flow cytometry. Guidelines of the Russian-Belarusian multicenter group for pediatric acute leukemia studies |
(Rus)
|
| Vol 23, No 1 (2024) |
ORIGINAL ARTICLES |
The prognostic value of TP53 mutational status in children with Burkitt lymphoma treated according to the B-NHL-2010M protocol |
(Rus)
|
| Vol 22, No 4 (2023) |
ORIGINAL ARTICLES |
Flow cytometric and cytomorphological definition of remission achievement in children with B-lineage acute lymphoblastic leukemia |
(Rus)
|
| Vol 22, No 4 (2023) |
DIAGNOSTIC GUIDELINES |
Guidelines for the use of flow cell sorting in diagnosis and monitoring of acute leukemia |
(Rus)
|
| Vol 23, No 1 (2024) |
ORIGINAL ARTICLES |
Bispecific monoclonal antibody blinatumomab in the first-line therapy of B-lineage acute lymphoblastic leukemia in children and adolescents: interim results of the Russian Ministry of Health approbation protocol |
(Rus)
|
| Vol 23, No 1 (2024) |
ORIGINAL ARTICLES |
The use of blinatumomab in children with de novo Ph-negative B-lineage acute lymphoblastic leukemia and slow clearance of minimal residual disease |
(Rus)
|
| Vol 23, No 1 (2024) |
ORIGINAL ARTICLES |
Flow cytometric and cytomorphological definition of remission achievement in children with acute myeloid leukemia |
(Rus)
|
| Vol 23, No 1 (2024) |
ORIGINAL ARTICLES |
Tolerability and toxicity of induction chemoimmunotherapy with dinutuximab beta in newly diagnosed patients with high-risk neuroblastoma |
(Rus)
|
| Vol 23, No 1 (2024) |
DIAGNOSTIC GUIDELINES |
Immunophenotyping in the diagnosis of acute leukemias of ambiguous lineage. The results of centralized diagnosis and practical guidelines |
(Rus)
|
| Vol 23, No 3 (2024) |
ORIGINAL ARTICLES |
Second malignant neoplasms after neuroblastoma treatment: a single center experience |
(Rus)
|
| Vol 23, No 2 (2024) |
ORIGINAL ARTICLES |
The clinical course of the novel coronavirus disease in children after allogeneic hematopoietic stem cell transplantation |
(Rus)
|
| Vol 23, No 3 (2024) |
ORIGINAL ARTICLES |
Low-grade gliomas of the brainstem in children: stratification into risk groups and the assessment of the effectiveness of targeted therapy |
(Rus)
|
| Vol 23, No 3 (2024) |
ORIGINAL ARTICLES |
Epidemiology, clinical features and prognosis for medulloblastoma relapse depending on the molecular subgroups in children and adolescents |
(Rus)
|
| Vol 23, No 4 (2024) |
ORIGINAL ARTICLES |
Transient abnormal myelopoiesis, myelodysplastic syndrome and acute myeloid leukemia in children with Down syndrome |
(Rus)
|
| Vol 23, No 4 (2024) |
ORIGINAL ARTICLES |
Epidemiology of acquired aplastic anemia in children in the Russian Federation |
(Rus)
|
| Vol 23, No 4 (2024) |
ORIGINAL ARTICLES |
Genetic diversity in pediatric patients with inborn errors of immunity in Russia |
(Rus)
|
| Vol 24, No 1 (2025) |
ORIGINAL ARTICLES |
The results of a registry study on acute myeloid leukemia in Russian children |
(Rus)
|
| Vol 24, No 1 (2025) |
ORIGINAL ARTICLES |
The prognostic significance of partner genes and breakpoint locations in children with KMT2A-rearranged acute myeloid leukemia |
(Rus)
|
| Vol 24, No 1 (2025) |
ORIGINAL ARTICLES |
The prognostic value of FLT3-ITD in different cytogenetic and molecular genetic subgroups of pediatric acute myeloid leukemia |
(Rus)
|
| Vol 24, No 1 (2025) |
ORIGINAL ARTICLES |
Pediatric non-Down syndrome acute megakaryoblastic leukemia with GATA1 mutations |
(Rus)
|
| Vol 24, No 1 (2025) |
ORIGINAL ARTICLES |
Preliminary results of treatment of intermediate-risk patients according to the AML-MRD-2018 protocol |
(Rus)
|
| Vol 24, No 1 (2025) |
ORIGINAL ARTICLES |
Outcomes of treatment of childhood acute promyelocytic leukemia according to the APL 2003/2008 protocols in Russia and Belarus |
(Rus)
|
| Vol 24, No 1 (2025) |
ORIGINAL ARTICLES |
Pegylated asparaginase during induction therapy in children with intermediate-risk acute lymphoblastic leukemia: results of a randomized study |
(Rus)
|
